EXPRESSION OF MARKERS OF HYPOXIA, ANGIOGENESIS, AS MICROCIRCULATORY-TISSUE FACTORS IN PROLIFERATIVE PROCESSES OF THE ENDOMETRIUM

Authors

  • Z. V. Chumak Odesa National Medical University City Centre of Menopause, Odesa
  • M. V. Shapoval Odesa National Medical University
  • О. М. Nadvorna Odesa National Medical University
  • O. V. Zhovtenko Odesa National Medical University

DOI:

https://doi.org/10.11603/24116-4944.2020.2.11863

Keywords:

endometrial hyperplasia, atypical endometrial hyperplasia, HIF-1α, VEGF, malignancy

Abstract

The aim of the study – to learn the expression of VEGF and HIF-1α in physiological, hyperplastic, atypical endometrium at different ages of women.

Materials and Methods. Evaluation of VEGF expression and HIF-1α performed in endometrial tissue samples in 458 women of late reproductive, perimenopausal and postmenopausal age. Expression of VEGF and HIF-1α was performed at the mRNA level by polymerase chain reaction of cDNA obtained by reverse transcription. The results were processed by the method of variation statistics with the assessment of reliability according to the Student's criterion using standard computer systems.

Results and Discussion. Analyzing the data of the presented work, higher VEGF expression rates were found in atypical hyperplasia in all age categories, but probably higher rates were found in the postmenopausal period, in atypical endometrial hyperplasia, which indicates the need for vigilance in detecting this process in the appropriate age category. Studies have shown that HIF-1α can potentiate the activation of vasomotor genes that are required for the vascular response to hypoxia. These studies demonstrate the informativeness of the method of determining HIF-1α in the examination of patients with endometrial hyperplastic processes (EHP). The introduction of this method in practical medicine will not only understand the details of the changes occurring in the body (pathological, physiological), but also develop strategic maneuvers for possible therapeutic or surgical treatments.

Conclusions. Expression of VEGF and HIF-1α levels in endometrial tissue cells as a marker can be a promising method for diagnosing the risk of proliferative conditions and their prognosis, especially in combination with other markers that characterize immunohistochemical and molecular genetic cellular parameters. Hypoxia and its relationship with indicators of angiogenesis may have some promising significance. Because the development of pathological conditions develops at a certain stage of hypoxic conditions. Under certain conditions, as a result of disruption of tissue processes, possibly metabolic, changes in angiogenesis are reduced with increasing hypoxia, which may in the long run provoke atypical disorders.

Author Biographies

Z. V. Chumak, Odesa National Medical University City Centre of Menopause, Odesa

Candidate of Medical Sciences, Assistant of the Department of Obstetrics and Gynecology of Odessa National Medical University, Doctor of Odessa City Menopause Center

M. V. Shapoval, Odesa National Medical University

Doctor of Medical Sciences, Professor of the Department of Obstetrics and Gynecology, Odessa National Medical University

О. М. Nadvorna, Odesa National Medical University

Candidate of Medical Sciences, Assistant of the Department of Obstetrics and Gynecology, Odessa National Medical University

O. V. Zhovtenko, Odesa National Medical University

Candidate of Medical Sciences, Department of Obstetrics and Gynecology, Odessa National Medical University

References

Blokhin, D.Yu. (2009). “Postgenomnyy vzglyad” na problemy onkogeneza ["Postgenomic view" on the problems of oncogenesis]. Klinicheskaya onkogematologiya – Clinical Oncohematology, 2 (3), 277-283 [in Russian].

Gershteyn, Ye.S., Kushlinskiy, D.N., & Tereshkina, I.V. (2015). Faktor rosta endoteliya sosudov i opukholi zhenskoy reproduktivnoy sistemy. Ch. 2. Rak yaichnikov i endometriya [Growth factor of vascular endothelium and tumors of the female reproductive system. Part 2]. Fundamentalnaya onkologiya – Fundamental Oncology, 2, 2-11 [in Russian].

Vovk, I.B., Gorban, N.Ye., & Borisyuk, O.Yu. (2016). Giperplaziya endometriya (Klinicheskaya lektsiya) [Endometrial hyperplasia (Clinical lecture)]. Zdorovye zhenshchiny – Womens Health, 5 (111), 10-18 [in Russian].

Kazachkova, E.A., Kazachkov, Ye.L., Zatvornitskaya, A.V., & Voropayeva, Ye.Ye. (2019). Gipoksicheskoye povrezhdeniye i neovaskulyarizatsiya endometriya pri giperplazii slizistoy obolochki matki [Hypoxic damage and neovascularization of the endometrium in hyperplasia of the uterine mucosa]. RMZh. Mat i ditya – RMJ. Mother and child., 3, 232-235 [in Russian].

Hrokhovska, M.V. (2015). Otsinka klitynnykh protsesiv pry hiperplaziiakh endometriiu u zhinok z ekstrahenitalnoiu patolohiieiu [Evaluation of cellular processes in endometrial hyperplasia in women with extragenital pathology]. Arkhiv klinichnoi medytsyny – Archive of Clinical Medicine, 1 (21), 11-13 [in Ukrainian].

Levakov, S.A., Sheshukova, N.A., Kedrova, A.G., Fedotova, A.S., & Obukhova, Ye.A. (2018). Molekulyarno-biologicheskiye profili giperplazii endometriya i endometrialnoy intraepitelialnoy neoplazii [Molecular-biological profiles of endometrial hyperplasia and endometrial intrapepithelial neoplasia]. Opukholi zhenskoy reproduktivnoy sistemy – Tumors of the Female Reproductive System, 14 (2), 76-81 [in Russian].

Orazov, M.R. (2015). Diskussionnyye voprosy vedeniya patsiyentok s giperplaziyey endometriya [Discussion issues of management of patients with endometrial hyperplasia]. Aku­sherstvo i ginekologiya: novosti, mneniya, obucheniye – Obstetrics and Gynecology: News, Opinions, Training, 3, 46-58 [in Russian].

Tatarchuk, T.F., Kalugina, L.V., & Tutchenko, T.N. (2015). Giperplasticheskiye protsessy endometriya: chto novogo? [Endometrial hyperplastic processes: what's new?]. Reproduktivna endokrinologiya – Reproductive Endocrinology, 5 (25), 7-13 [in Russian].

Chernukha G.Ye., Asaturova A.V., Ivanov I.A., & Dumanovskaya M.R. (2018). Struktura patologii endometriya v razlichnyye vozrastnyye periody [The structure of endometrial pathology in different age periods]. Akusherstvo i ginekologiya – Obstetrics and Gynecology, 8, 129-134 [in Russian].

Chumak, Z.V., Zelinskiy, A.A., & Shapoval, N.V. (2015). Immunogistokhimicheskiye i molekulyarno geneticheskiye markery giperplazirovannogo i neoplazirovannogo endometriya [Immunohistochemical and molecular genetic markers of hyperplastic and unoplastic endometrium]. Visnyk morfolohii – Bulletin of Morphology, 21 (2), 547-552 [in Russian].

Zvershanovskii, F.A., & Zhulkevich, I.V. (1987). Effect of hyperbaric oxygenation on free-radical processes and gastric acid production in patients with duodenal ulcer. Ter. Arkh., 59 (2), 53-55.

Zimna, A., & Kurpisz, M. (2015). Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies. BioMed Res. Int., 2015, ID 549412, 13. – Access mode : https://doi.org/10.1155/2015/549412.

Zhao, D., Qu, Q., Dai, H., Liu, Y., Jiang, L., Huang, X., & Hao, C. (2017). Effects of hypoxiainducible factor1α on endometrial receptivity of women with polycystic ovary syndrome. Mol. Med. Rep., 17 (1), 414-421.

Yu, X., Gao, C., Dai, C., Yang, F., & Deng, X. (2019). Endometrial injury increases expression of hypoxia-inducible factor and angiogenesis in the endometrium of women with recurrent implantation failure. Reprod. Biomed. Online, 38 (5), 761-767.

Elfayomy, A.K., Almasry, S.M., Attia, G.M., & Habib, F.A. (2015). Enhanced expression of vascular endothelial growth factor and increased microvascular density in women with endometrial hyperplasia: a possible relationship with uterine natural killer cells. Rom. J. Morphol. Embryol., 56 (2 Suppl.), 725-734.

Wang, J., Taylor, A., Showeil, R., Trivedi, P., Horimoto, Y., Bagwan, I., …, & El-Bahrawy, M.A. (2014). Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma. Cytokine, 68 (2), 94-100.

Maybin, J.A., Murray, A.A., Saunders, P.T.K., Hirani, N., Carmeliet, P., & Critchley, H.O.D. (2018). Hypoxia and hypoxia inducible factors-1α are required for normal endometrial repair during menstruation. Nat. Commun., 9, 295.

Chen, X., Liu, J., He, B., Li, Y., Liu, S., Wu, B., …, & Wang, J. (2015). Vascular endothelial growth factor (VEGF) regulation by hypoxia inducible factor-1 alpha (HIF1A) starts and peaks during endometrial breakdown, not repair, in a mouse menstrual-like model. Hum. Reprod., 30 (9).

Sanderson, P.A., Critchley, H.O.D., Williams, A.R.W., Arends, M.J., & Saunders, P.T.K. (2017). New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum. Reprod. Update, 23 (2), 232-254.

Lacey, J.V.Jr., & Chia, V.M. (2009). Endometrial hyperplasia and the risk of progression to carcinoma. Maturitas, 63, 39-44.

Kryvokulskyi, B.D., Zhulkevych, I.V., Kryvokulskyi, D.B., & Shkrobot, L.V. (2018). Vyvchennia vplyvu viku ta indeksu komorbidnosti na ryzyk trombotychnykh uskladnen u khvorykh na rak endometriia na dooperatsiinomu etapi [Studying the influence of age and comorbidity index on the thrombotic complications risk in patients with endometrial cancer at preoperative stage]. Visnyk naukovykh doslidzhen – Bull. Sci. Res., 2 (91), 151-153 [in Ukrainian].

Vetter, M.H., Smith, B., Benedict, J., Hade, E.M., Bixel, K., Copeland, L.J., …, & Backes, F.J. (2020). Preoperative predictors of endometrial cancer at the time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia. Am. J. Obstet. Gynecol., 222 (1), 60.e1-60.e7.

Goldstein, S.R., & Lumsden, M.A. (2017). Abnormal uterine bleeding in perimenopause. Climacteric, 20 (5), 414-420.

Horban, N.Y., Vovk, I.B., Lysiana, T.O., Ponomariova, I.H., & Zhulkevych, I.V. (2019). Peculiarities of uterine cavity biocenosis in patients with different types of endometrial hyperproliferative pathology. J. Med. Life., 12 (3), 266-270.

Ozelci, R., Dilbaz, B., Akpınar, F., Kınay, T., Baser, E., Aldemir, O., & Altınbas, S.K. (2019). The significance of sonographically thickened endometrium in asymptomatic postmenopausal women. Obstet. Gynecol. Sci., 62 (4), 273-279.

Published

2021-03-04

How to Cite

Chumak, Z. V., Shapoval, M. V., Nadvorna О. М., & Zhovtenko, O. V. (2021). EXPRESSION OF MARKERS OF HYPOXIA, ANGIOGENESIS, AS MICROCIRCULATORY-TISSUE FACTORS IN PROLIFERATIVE PROCESSES OF THE ENDOMETRIUM. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 197–202. https://doi.org/10.11603/24116-4944.2020.2.11863

Issue

Section

OBSTETRICS AND GYNECOLOGY